Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 80.44B | 80.49B | 80.47B | 80.85B | 86.79B | 76.56B |
Gross Profit | 25.90B | 26.20B | 25.91B | 25.24B | 30.86B | 26.55B |
EBITDA | 6.95B | 8.86B | 10.64B | 10.42B | 13.92B | 11.62B |
Net Income | 3.71B | 4.15B | 5.45B | 5.86B | 7.79B | 6.16B |
Balance Sheet | ||||||
Total Assets | 160.24B | 157.76B | 164.82B | 155.94B | 155.46B | 150.06B |
Cash, Cash Equivalents and Short-Term Investments | 17.99B | 21.06B | 16.42B | 9.56B | 22.69B | 19.88B |
Total Debt | 5.73B | 5.59B | 5.79B | 2.52B | 3.08B | 3.05B |
Total Liabilities | 33.63B | 33.40B | 35.40B | 35.36B | 36.88B | 35.61B |
Stockholders Equity | 126.61B | 124.36B | 129.42B | 120.58B | 118.58B | 114.45B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 7.50B | 4.59B | -9.55B | 5.66B | 3.50B |
Operating Cash Flow | 0.00 | 11.54B | 7.91B | -7.59B | 8.43B | 6.60B |
Investing Cash Flow | 0.00 | -2.14B | -1.06B | 853.00M | -2.39B | -3.33B |
Financing Cash Flow | 0.00 | -4.71B | -533.00M | -6.35B | -2.90B | -2.65B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | ¥91.49B | 21.33 | 4.88% | 0.03% | -23.96% | ||
63 Neutral | $34.04B | 6.14 | -11.52% | 1.82% | 5.53% | -18.79% | |
€952.52M | 14.00 | 10.97% | 2.70% | ― | ― | ||
$4.17B | 10.75 | 6.70% | 4.15% | ― | ― | ||
$618.42M | 19.44 | 15.32% | 0.02% | ― | ― | ||
€953.47M | 5.15 | 30.22% | 1.69% | ― | ― | ||
75 Outperform | ¥101.91B | 14.00 | 2.81% | 8.95% | 4.60% |